kd101
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2013 (NCT01979380)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Melanocortin receptor 1AGONIST
MC1R agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- kd101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02819934 | Phase 1 | May 1, 2016 | Seoul National University |
| NCT02462031 | Phase 1 | Mar 1, 2015 | Kwang Dong Pharmaceutical co., ltd., Seoul National University |
| NCT01979380 | Phase 1 | Dec 1, 2013 | Kwang Dong Pharmaceutical co., ltd., Seoul National University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Seoul National University | Academic/Hospital | 3 | 1 | 1 | 2013 |
| Kwang Dong Pharmaceutical co., ltd. | For profit | 2 | 2 | 1 | 2013 |
2 organizations
Page 1 / 1